Clinical Trials Browser

Phase 2 × Lung Neoplasms × canakinumab × Clear all

NCT06038526 2026-02-19

Evaluation of Canakinumab in High-Risk Former-Smokers

Phase 2 Active not recruiting

Lung Neoplasms

NCT04789681 2025-12-26

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

Phase 2 Recruiting

Lung Neoplasms